Adipose tissue and adipokines: the association with and application of adipokines in obesity
- PMID: 25309775
- PMCID: PMC4182896
- DOI: 10.1155/2014/328592
Adipose tissue and adipokines: the association with and application of adipokines in obesity
Abstract
2014 marks the 20th anniversary of adipokines. Through the identification of leptin, our perceived understanding of adipose tissue was changed instantaneously. From a simple dormant site of energy storage, adipose tissue is now recognized as an integral hub of various hormones known as adipokines. Although great strides have been made in characterizing these hormones in health, research also shows they are significantly implicated in a series of pathologies. One such condition is obesity. Defined as an excess of adipose tissue, obesity remains one of the greatest healthcare epidemics of the 21st century. With no definitive treatment, attention has shifted to understanding the role of adipokines in obesity. This review provides an introduction to the salient obesity-related adipokines and their possible application as a treatment for obesity.
Figures
References
-
- Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nature Medicine. 2006;12(1):75–80. - PubMed
-
- Ravussin E, Swinburn BA. Pathophysiology of obesity. The Lancet. 1992;340(8816):404–408. - PubMed
-
- Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology & Metabolism. 2004;89(6):2548–2556. - PubMed
-
- Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372(6505):425–432. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
